SIGMA-TAU INTERNATIONAL/DOR BIOPHARMA - SCHEDULE 13G

Company

SOLIGENIX, INC.

Filed

December 3, 2008

Accession Number

0000950162-08-000528

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →